William Hoffman - 06 Jul 2022 Form 4 Insider Report for Inari Medical, Inc.

Role
President and CEO, Director
Signature
/s/ Angela Ahmad, attorney-in-fact for William Hoffman
Issuer symbol
N/A
Transactions as of
06 Jul 2022
Net transactions value
-$3,159,492
Form type
4
Filing time
08 Jul 2022, 16:39:26 UTC
Previous filing
06 Jul 2022
Next filing
12 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Options Exercise $12,852 +30,000 +5.5% $0.4284* 578,899 06 Jul 2022 Direct F1
transaction NARI Common Stock Sale $1,440,123 -20,077 -3.5% $71.73 558,822 06 Jul 2022 Direct F1, F2
transaction NARI Common Stock Sale $660,870 -9,123 -1.6% $72.44 549,699 06 Jul 2022 Direct F1, F3
transaction NARI Common Stock Sale $58,672 -800 -0.15% $73.34 548,899 06 Jul 2022 Direct F1, F4
transaction NARI Common Stock Sale $1,012,679 -13,488 -2.5% $75.08 535,411 07 Jul 2022 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NARI Stock Option Options Exercise $0 -30,000 -9.4% $0.000000 290,168 06 Jul 2022 Common Stock 30,000 $0.4284 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $71.14 to $72.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $72.14 to $73.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $73.26 to $73.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $75.00 to $75.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 The option is vested and exercisable as to 133,231 shares, and the remaining shares will vest and become exercisable in equal monthly installments until December 13, 2022.